Logo image
Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases
Journal article   Open access   Peer reviewed

Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases

Louise A. Mesentier-Louro, Camila Zaverucha-do-Valle, Paulo H. Rosado-de-Castro, Almir J. Silva-Junior, Pedro M. Pimentel-Coelho, Rosalia Mendez-Otero and Marcelo F. Santiago
Stem cells international, Vol.2016(2016), pp.1-16
01/01/2016
DOI: 10.1155/2016/5078619
PMCID: PMC4663341
PMID: 26649049
url
https://doi.org/10.1155/2016/5078619View
Published (Version of record) Open Access

Abstract

Following optic nerve injury associated with acute or progressive diseases, retinal ganglion cells (RGCs) of adult mammals degenerate and undergo apoptosis. These diseases have limited therapeutic options, due to the low inherent capacity of RGCs to regenerate and due to the inhibitory milieu of the central nervous system. Among the numerous treatment approaches investigated to stimulate neuronal survival and axonal extension, cell transplantation emerges as a promising option. This review focuses on cell therapies with bone marrow mononuclear cells and bone marrow-derived mesenchymal stem cells, which have shown positive therapeutic effects in animal models of optic neuropathies. Different aspects of available preclinical studies are analyzed, including cell distribution, potential doses, routes of administration, and mechanisms of action. Finally, published and ongoing clinical trials are summarized.
Review

Details

Metrics

Logo image